In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects

Condition:   Fibrodysplasia Ossificans ProgressivaIntervention:   Drug: PalovaroteneSponsor:   Clementia Pharmaceuticals Inc.Not yet recruiting - verified August 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials